References:
  1. WHO. World Health Organization Emergency COVID-19 Dashboard. https://extranet.who.int/publicemergency. Accessed on 4/8/2020.
  2. MacLaren G, Fisher D, Brodie D. Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation. JAMA 2020; published online Feb 19. DOI:10.1001/jama.2020.2342.
  3. Davies A, Jones D, Bailey M, et al. Extracorporeal membrane oxygenation for 2009 Influenza A(H1N1) acute respiratory distress syndrome. JAMA 2009; 302: 1888–95.
  4. Arabi YM, Al-Omari A, Mandourah Y, et al. Critically ill patients with the Middle East respiratory syndrome: a multicenter retrospective cohort study. Crit Care Med 2017; 45: 1683–95.
  5. Enforcement Policy for Extracorporeal Membrane Oxygenation and Cardiopulmonary Bypass Devices during the Coronavirus Disease 2019 (COVID-19) Public Health Emergency. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-extracorporeal-membrane-oxygenation-and-cardiopulmonary-bypass-devices-during?utm_campaign=2020-04-06%20COVID-19%20ECMO%20Therapy%20Devices&utm_medium=email&utm_source=Eloqua. Accessed on April 8th, 2020.
  6. Ramanathan K, Antognini D, Combes A, et al. Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases. Lancet Respir Med. 2020. Published online March 20, 2020. https://doi.org/10.1016/52213-2600(20)30121-1.
  7. “Extracorporeal Life Support Organization COVID-19 Interim Guidelines: A consensus document from an international group of interdisciplinary ECMO providers”. https://www.elso.org/COVID19.aspx Accessed April 9th, 2020.
  8. Interim Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) in Healthcare Settings. https://www.cdc.gov/coronavirus/2019-ncov/infection-control/control-recommendations.html. Accessed April 9th, 2020.